SG10201906981TA - Methods and reagents for the assessment of gestational diabetes - Google Patents
Methods and reagents for the assessment of gestational diabetesInfo
- Publication number
- SG10201906981TA SG10201906981TA SG10201906981TA SG10201906981TA SG10201906981TA SG 10201906981T A SG10201906981T A SG 10201906981TA SG 10201906981T A SG10201906981T A SG 10201906981TA SG 10201906981T A SG10201906981T A SG 10201906981TA SG 10201906981T A SG10201906981T A SG 10201906981TA
- Authority
- SG
- Singapore
- Prior art keywords
- assessment
- gestational diabetes
- reagents
- methods
- kits
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361911306P | 2013-12-03 | 2013-12-03 | |
| US201461945860P | 2014-02-28 | 2014-02-28 | |
| US201461946373P | 2014-02-28 | 2014-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201906981TA true SG10201906981TA (en) | 2019-09-27 |
Family
ID=53274086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201906981TA SG10201906981TA (en) | 2013-12-03 | 2014-12-03 | Methods and reagents for the assessment of gestational diabetes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10732186B2 (de) |
| EP (2) | EP3620793A1 (de) |
| JP (2) | JP6542219B2 (de) |
| KR (1) | KR20160092006A (de) |
| CN (2) | CN109917125A (de) |
| AU (1) | AU2014360539A1 (de) |
| CA (1) | CA2932607A1 (de) |
| IL (2) | IL245925B (de) |
| MX (1) | MX371298B (de) |
| SG (1) | SG10201906981TA (de) |
| WO (1) | WO2015084994A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2826020C (en) * | 2011-02-10 | 2020-12-01 | President And Fellows Of Harvard College | Surrogates of post-translationally modified proteins and uses thereof |
| CN105181869B (zh) * | 2015-09-21 | 2016-05-18 | 南京医科大学 | 一种巨大儿辅助诊断标志物的应用 |
| WO2017123666A2 (en) * | 2016-01-11 | 2017-07-20 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | In vivo positron emission tomography-based perfusion/blood pool imaging using labeled erythrocytes |
| US11866506B2 (en) | 2017-04-21 | 2024-01-09 | Mellitus, Llc | Anti-CD59 antibodies |
| RU2703342C1 (ru) * | 2018-11-19 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Прогнозирование развития гестационного сахарного диабета у первородящих юного возраста |
| RU2710498C1 (ru) * | 2019-03-04 | 2019-12-26 | федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ прогнозирования высокого риска развития пролиферативной диабетической ретинопатии у беременных с сахарным диабетом 1 типа |
| CN112924682B (zh) * | 2019-12-05 | 2023-02-10 | 张曼 | 尿液纤维蛋白原α链蛋白及其多肽片段在正常妊娠中的应用 |
| KR102525374B1 (ko) | 2020-12-16 | 2023-04-24 | 가톨릭대학교 산학협력단 | 고위험 임신성 당뇨병 예측모델 설계 방법 및 장치 |
| CN113009152B (zh) * | 2021-02-19 | 2022-05-10 | 山东省大健康精准医疗产业技术研究院 | 一种糖基化cd59酶联免疫检测试剂盒及其制备方法与应用 |
| CN112904009B (zh) * | 2021-02-19 | 2022-03-18 | 山东莱博生物科技有限公司 | 一种检测糖基化cd59的磁性微球检测试剂盒及其应用 |
| WO2022241236A2 (en) * | 2021-05-13 | 2022-11-17 | Mellitus, Llc | Methods and reagents for protein analysis |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| FR2619568B1 (fr) * | 1987-08-21 | 1989-07-07 | Centre Nat Rech Scient | Polymeres derives du polystyrene, leurs procedes de preparation et leurs applications pour l'analyse et la purification de molecules d'origine biologique |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| GB9110962D0 (en) * | 1991-05-21 | 1991-07-10 | Ici Plc | Process |
| ATE297465T1 (de) | 1991-11-25 | 2005-06-15 | Enzon Inc | Verfahren zur herstellung von multivalenten antigenbindenden proteinen |
| AU670108B2 (en) * | 1992-09-11 | 1996-07-04 | Becton Dickinson & Company | Improved antibodies to plasmodium falciparum |
| US5407912A (en) | 1993-04-19 | 1995-04-18 | Akzo, N.V. | Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
| US5675063A (en) | 1995-02-28 | 1997-10-07 | Loyola University Of Chicago | Immortalized rabbit hybridoma fusion partner |
| US5670377A (en) * | 1996-03-14 | 1997-09-23 | Sansum Medical Research Foundation | Method of diagnosing gestational diabetes |
| US6348584B1 (en) | 1996-10-17 | 2002-02-19 | John Edward Hodgson | Fibronectin binding protein compounds |
| US6323361B1 (en) * | 1997-04-17 | 2001-11-27 | Corning Inc. | Photocurable halofluorinated acrylates |
| EP0985039B1 (de) | 1997-06-12 | 2008-02-20 | Novartis International Pharmaceutical Ltd. | Künstliche antikörperpolypeptide |
| DE1075286T1 (de) * | 1998-05-06 | 2002-05-23 | Isotechnika,Inc. | 13C-Glukose-Atemtest zur Diagnose von Diabetes-Indikationen und Überwachung der glykämischen Kontrolle |
| US7439330B2 (en) | 2000-05-08 | 2008-10-21 | President And Fellows Of Harvard College | Anti-glycated CD59 antibodies and uses thereof |
| US6835545B2 (en) | 2000-05-08 | 2004-12-28 | President And Fellows Of Harvard College | Methods, products and treatments for diabetes |
| JP2003055366A (ja) * | 2001-08-20 | 2003-02-26 | Shiseido Co Ltd | ラクトン誘導体、並びに、これを有効成分とする植物成長調整剤および発根誘導剤 |
| WO2004016740A2 (en) | 2002-08-15 | 2004-02-26 | Epitomics, Inc. | Humanized rabbit antibodies |
| US20040067496A1 (en) | 2002-10-07 | 2004-04-08 | Robert Pytela | System for production and screening of monoclonal antibodies |
| AU2003259718A1 (en) | 2003-08-07 | 2005-03-07 | Epitomics, Inc. | Methods for humanizing rabbit monoclonal antibodies |
| EP2348050B1 (de) | 2004-06-17 | 2017-10-25 | President and Fellows of Harvard College | Anti-glycosilierte cd59-antikörper und ihre verwendung |
| US7462697B2 (en) | 2004-11-08 | 2008-12-09 | Epitomics, Inc. | Methods for antibody engineering |
| WO2006086098A2 (en) | 2005-01-06 | 2006-08-17 | President And Fellows Of Harvard College | Mass spectrometric methods and products |
| US7429487B2 (en) | 2005-07-05 | 2008-09-30 | Epitomics, Inc. | Fusion partner for production of monoclonal rabbit antibodies |
| WO2008137165A1 (en) | 2007-05-07 | 2008-11-13 | President And Fellows Of Harvard College | Anti-glycated cd59 antibodies and uses thereof |
| WO2010025510A1 (en) | 2008-09-03 | 2010-03-11 | Xenome Ltd | Libraries of peptide conjugates and methods for making them |
| US20120027658A1 (en) * | 2010-07-30 | 2012-02-02 | Karwacki Christopher J | Oxidation Catalysts Useful for Ambient Temperature Operation |
| US9068006B2 (en) | 2010-08-25 | 2015-06-30 | President And Fellows Of Harvard College | Glycated CD59 peptides, their preparation, and uses thereof |
| CA2826020C (en) | 2011-02-10 | 2020-12-01 | President And Fellows Of Harvard College | Surrogates of post-translationally modified proteins and uses thereof |
| US20140322723A1 (en) | 2011-11-22 | 2014-10-30 | President and Dellows of Harvard College | Diabetes diagnosis through the detection of glycated proteins in urine |
| CN102590491B (zh) * | 2012-02-06 | 2014-12-10 | 中国人民解放军第三军医大学第一附属医院 | 一种用于早期筛查或辅助诊断泌尿系统疾病的检测试剂盒、检测方法及其用途 |
| US9499634B2 (en) | 2012-06-25 | 2016-11-22 | Zymeworks Inc. | Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells |
-
2014
- 2014-12-03 CN CN201910250407.2A patent/CN109917125A/zh active Pending
- 2014-12-03 EP EP19186103.8A patent/EP3620793A1/de not_active Withdrawn
- 2014-12-03 MX MX2016007123A patent/MX371298B/es active IP Right Grant
- 2014-12-03 KR KR1020167017465A patent/KR20160092006A/ko not_active Application Discontinuation
- 2014-12-03 EP EP14867264.5A patent/EP3077815B1/de active Active
- 2014-12-03 JP JP2016535634A patent/JP6542219B2/ja active Active
- 2014-12-03 CN CN201480074004.2A patent/CN105934671B/zh active Active
- 2014-12-03 US US15/100,563 patent/US10732186B2/en active Active
- 2014-12-03 SG SG10201906981TA patent/SG10201906981TA/en unknown
- 2014-12-03 WO PCT/US2014/068426 patent/WO2015084994A1/en active Application Filing
- 2014-12-03 AU AU2014360539A patent/AU2014360539A1/en not_active Abandoned
- 2014-12-03 CA CA2932607A patent/CA2932607A1/en active Pending
-
2016
- 2016-05-30 IL IL245925A patent/IL245925B/en active IP Right Grant
-
2019
- 2019-01-30 IL IL264559A patent/IL264559A/en unknown
- 2019-06-12 JP JP2019109338A patent/JP2019191186A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016007123A (es) | 2017-02-15 |
| US10732186B2 (en) | 2020-08-04 |
| CN109917125A (zh) | 2019-06-21 |
| IL245925A0 (en) | 2016-07-31 |
| CN105934671B (zh) | 2019-04-19 |
| EP3077815A4 (de) | 2017-06-21 |
| IL264559A (en) | 2019-02-28 |
| EP3077815B1 (de) | 2019-07-17 |
| EP3620793A1 (de) | 2020-03-11 |
| EP3077815A1 (de) | 2016-10-12 |
| KR20160092006A (ko) | 2016-08-03 |
| US20160299150A1 (en) | 2016-10-13 |
| JP6542219B2 (ja) | 2019-07-10 |
| IL245925B (en) | 2019-02-28 |
| CN105934671A (zh) | 2016-09-07 |
| AU2014360539A1 (en) | 2016-06-23 |
| JP2019191186A (ja) | 2019-10-31 |
| MX371298B (es) | 2020-01-23 |
| WO2015084994A1 (en) | 2015-06-11 |
| JP2017502267A (ja) | 2017-01-19 |
| CA2932607A1 (en) | 2015-06-11 |
| US20170108505A2 (en) | 2017-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201906981TA (en) | Methods and reagents for the assessment of gestational diabetes | |
| WO2013096822A3 (en) | Test device for optical and electrochemical assays | |
| MX2015012823A (es) | Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo. | |
| EP3991848A3 (de) | Hochdurchsatzsystem zur durchführung von assays unter verwendung von elektrochemilumineszenz mit einer verbrauchsmaterialschüttelvorrichtung | |
| WO2013052505A3 (en) | Methods and devices for assessing risk to a putative offspring of developing a condition | |
| MY161291A (en) | Antibody, kit and method for determination of amyloid peptides | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| WO2015158868A3 (en) | Methods, kits and apparatus for expanding a population of cells | |
| WO2011159537A3 (en) | Method and device for analyte detection | |
| MX2016004167A (es) | Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal. | |
| MX2016005834A (es) | Ensayos para igfbp7 con mejor rendimiento en muestras biológicas. | |
| WO2016023991A8 (de) | Verfahren zur mikrobiom-analyse | |
| WO2019105468A8 (en) | Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody | |
| WO2015148609A3 (en) | Immunoassays using colloidal crystals | |
| WO2014091490A3 (en) | Diagnosis of autoimmune diseases using a specific antibody profile | |
| JP2021503610A5 (de) | ||
| WO2012175602A3 (en) | Elisa for calprotectin | |
| WO2018085431A8 (en) | Filamin a binding proteins and uses thereof | |
| WO2014160237A3 (en) | Methods of prognosing preeclampsia | |
| WO2016012864A3 (en) | Biomarkers for anderson-fabry disease | |
| GB201119585D0 (en) | Assay | |
| GB201114909D0 (en) | Biomarkers for lysosomal storage disorders | |
| EP2913675A3 (de) | GP2-Isoformen und deren Verwendung bei der Autoantikörpererfassung | |
| MX2021003484A (es) | Metodos para detectar efecto(s) hook asociado(s) con analito(s) de interes durante o que resulta(n) de la realizacion de ensayo(s) de diagnostico. | |
| WO2018176030A3 (en) | Antibodies and immunoassays for detection of bmp-15 and gdf-9 isoforms |